Cilostazol: a review of basic mechanisms and clinical uses

RY Kherallah, M Khawaja, M Olson, D Angiolillo… - … drugs and therapy, 2022 - Springer
Primarily used in the treatment of intermittent claudication, cilostazol is a 2-oxyquinolone
derivative that works through the inhibition of phosphodiesterase III and related increases in …

Molecular mechanisms and current treatment options for cancer cachexia

SS Ahmad, K Ahmad, S Shaikh, HJ You, EY Lee, S Ali… - Cancers, 2022 - mdpi.com
Simple Summary The primary characteristics of cancer cachexia are weakness, weight loss,
atrophy, fat reduction, and systemic inflammation. Cachexia is strongly associated with …

Combined carvacrol and cilostazol ameliorate ethanol-induced liver fibrosis in rats: Possible role of SIRT1/Nrf2/HO-1 pathway

SE Abu-Risha, SS Sokar, HR Elbohoty… - International …, 2023 - Elsevier
Carvacrol is a natural phenolic monoterpenoid, and cilostazol is a selective
phosphodiesterase-3 inhibitor with antioxidant, anti-inflammatory and antiapoptotic effects …

The cardioprotective effect of Corosolic Acid in the Diabetic rats: A possible mechanism of the PPAR-γ pathway

FK Alkholifi, S Devi, HS Yusufoglu, A Alam - Molecules, 2023 - mdpi.com
The study was conducted to determine whether corosolic acid could protect the myocardium
of diabetic rats from damage caused by isoproterenol (ISO) and, if so, how peroxisome …

The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis

M Sohn, S Lim - International Journal of Molecular Sciences, 2024 - mdpi.com
Atherosclerotic cardiovascular disease (ASCVD) stands as the leading global cause of
mortality. Addressing this vital and pervasive condition requires a multifaceted approach, in …

PPARγ in ischemia-reperfusion injury: overview of the biology and therapy

R Huang, C Zhang, X Wang, H Hu - Frontiers in Pharmacology, 2021 - frontiersin.org
Ischemia-reperfusion injury (IRI) is a complex pathophysiological process that is often
characterized as a blood circulation disorder caused due to various factors (such as …

Platelet Rich Plasma and Adipose-Derived Mesenchymal Stem Cells Mitigate Methotrexate-Induced Nephrotoxicity in Rat via Nrf2/Pparγ/HO-1 and NF-Κb/Keap1 …

FA Wani, MA Ibrahim, SH Ameen, AE Farage, ZAE Ali… - Toxics, 2023 - mdpi.com
Background: the nephrotoxicity of methotrexate (MTX) is observed in high-dose therapy.
Moreover, low-dose MTX therapy for rheumatic diseases is debatable and claimed to cause …

Empagliflozin and neohesperidin protect against methotrexate-induced renal toxicity via suppression of oxidative stress and inflammation in male rats

AT Osman, SMZ Sharkawi, MIA Hassan… - Food and Chemical …, 2021 - Elsevier
Kidney injury from chemotherapy is one of the worsening problems associated with
methotrexate (MTX) use. This work aims to examine the nephroprotective effects of …

Preclinical Investigation of Alpinetin in the Treatment of Cancer-Induced Cachexia via Activating PPARγ

Y Zhang, Y Zhang, Y Li, L Zhang, S Yu - Frontiers in Pharmacology, 2021 - frontiersin.org
The ongoing loss of skeletal muscle is a central event of cancer cachexia, and its
consequences include adverse effects on patient's quality of life and survival. Alpinetin (Alp) …

Novel insights into gut health: Cilostazol strengthens gut integrity by adjusting TLR-2/NF-κB/IL-23 and CD44/AKT/GSK-3β/cyclin-D1 trajectories in methotrexate …

SM Mansour, O Sabra, F El-Komy, K Ahmed… - European Journal of …, 2024 - Elsevier
Methotrexate (MTX)-induced gastrointestinal mucositis is a common adverse effect
characterized by redox imbalance and overproduction of inflammatory mediators that …